RAYNA GORSTEIN: Open Payments
NPI 1639869076 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 66 payments from 14 companies in 2025. Trend: 2023 $246 · 2024 $1,408 · 2025 $1,272
Food & beverage: $1,272
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $313 |
| Axsome Therapeutics, Inc. | 7 | $153 |
| Janssen Pharmaceuticals, Inc | 7 | $144 |
| Lundbeck LLC | 5 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Neurocrine BioSciences, Inc. | 3 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Neos Therapeutics, LP | 4 | $70 |
| Noven Therapeutics, LLC | 3 | $61 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
Products named: VRAYLAR, Auvelity, SPRAVATO, REXULTI, TRINTELLIX, INGREZZA, CAPLYTA, Xelstrym.
Industry payments across IL — which companies pay providers there.
